PCM Encore’s Abbott ABT Stock Holding History

PCM Encore’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,001	Closed	-$411K	–	460
2026 Q1	$411K	Buy	4,001 +863	+28%	+$97.4K	0.08%	241
2025 Q4	$393K	Buy	+3,138	New	+$400K	0.08%	243

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PCM Encore's ABT Position: Q2 2026 in Review

PCM Encore sold out of Abbott (ABT) in Q2 2026, closing a stake of 4,001 shares — an estimated $411K sold.

PCM Encore first reported a position in ABT in Q4 2025 and held it in 2 quarters. The position peaked at $411K in Q1 2026. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

PCM Encore reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
PCM Encore sold 4,001 Abbott shares in Q2 2026, an estimated $411K.
PCM Encore first reported a position in Abbott in Q4 2025 and held it in 2 quarters.
PCM Encore's Abbott position peaked at $411K in Q1 2026.
2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.